Placebo-controlled trial of fluoxetine and phenelzine for obsessive- compulsive disorder

American Journal of Psychiatry

Volumn 154, Issue 9, 1997, Pages 1261-1264

  Jenike, Michael A ^a   Baer, Lee ^a   Minichiello, William E ^a   Rauch, Scott L ^a   Lynn Buttolph, M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; PHENELZINE; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; COMPULSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; DRUG SCREENING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSESSION; PATIENT SELECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030874475     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.154.9.1261     Document Type: Article

References (19)

1. Jenike MA: Drug treatment of obsessive-compulsive disorder, in Obsessive-Compulsive Disorders: Theory and Management, 2nd ed. Edited by Jenike MA, Baer L, Minichiello WE. Chicago, Year Book, 1990, pp 249-282
2. Joel SW: Twenty month study of iproniazid therapy. Dis Nerv Syst 1959; 20:1-4
3. Jain VK, Swinson RP, Thomas JG: Phenelzine in obsessional neurosis (letter). Br J Psychiatry 1970; 117:237-238
4. Jenike MA: Rapid response of severe obsessive-compulsive disorder to tranylcypromine. Am J Psychiatry 1981; 138:1249-1250
5. Jenike MA, Surman OS, Cassem NH, Zusky P, Anderson WH: Monoamine oxidase inhibitors in obsessive-compulsive disorder. J Clin Psychiatry 1983; 44:131-132
6. Jenike MA: MAOI for obsessive-compulsive disorder (letter). Br J Psychiatry 1982; 140:159
7. Insel TR, Murphy DL, Cohen RM, Alterman I, Kilts C, Linnoila M: Obsessive-compulsive disorder: a double-blind trial of clomipramine and clorgyline. Arch Gen Psychiatry 1983; 40:605-612
8. Vallejo J, Olivares J, Marcos T, Bulbena A, Menchon JM: Clomipramine versus phenelzine in obsessive-compulsive disorder: a controlled clinical trial. Br J Psychiatry 1992; 161:665-670
9. Spitzer RL, Williams JBW, Gibbon M, First MB: Structured Clinical Interview for DSM-III-R - Patient Version (SCID-P). New York, New York State Psychiatric Institute, Biometrics Research, 1988
10. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62
11. Thoren P, Asberg M, Cronholm B, Jornestedt L, Traskman L: Clomipramine treatment of obsessive compulsive disorder, I: a controlled clinical trial. Arch Gen Psychiatry 1980; 37:1281-1285
12. Hamilton M: The assessment of anxiety states by rating. Br J Med Psychol 1959; 32:50-55
13. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, Heninger GR, Charney DS: The Yale-Brown Obsessive Compulsive Scale, I: development, use, and reliability. Arch Gen Psychiatry 1989; 46:1006-1011
14. Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR, Charney DS: The Yale-Brown Obsessive Compulsive Scale, II: validity. Arch Gen Psychiatry 1989; 46:1012-1016
15. Goodman WK, Price LH, Rasmussen SA, Delgado PL, Heninger GR, Charney DS: Efficacy of fluvoxamine in obsessive-compulsive disorder: a double-blind comparison with placebo. Arch Gen Psychiatry 1989; 46:36-44
16. Cohen J: Statistical Power Analysis for the Sciences, 2nd ed. Hillsdale, NJ, Lawrence Erlbaum Associates, 1988
17. Jenike MA, Baer L, Ballantine HT, Martuza RL, Tynes S, Giriunas I, Buttolph L, Cassem N: Cingulotomy for refractory obsessive-compulsive disorder: a long-term follow-up of 33 patients. Arch Gen Psychiatry 1991; 48:548-555
18. Baer L, Rauch SL, Ballantine HT, Martuza R, Cosgrove R, Cassem E, Giriunas I, Manzo P, Dimino C, Jenike MA: Cingulotomy for intractable obsessive-compulsive disorder: prospective longterm follow-up of 18 patients. Arch Gen Psychiatry 1995; 52: 384-392
19. Baer L, Breiter H, Goodman W, Rasmussen S, Eisen J, Barr L, Shera D, Jenike M: Symptom subtypes in obsessive compulsive disorder and relation to tic and personality disorders: a factor analytic study of 107 patients. J Abnorm Psychol (in press)